Medicare Enrolled

Dr. Henry Vanpala, M.D.

Gastroenterology · Raleigh, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
4822 SIX FORKS RD, Raleigh, NC 27609
9197951399
Registered in NPPES since 2012
NPI: 1710241658 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vanpala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vanpala? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vanpala

Dr. Henry Vanpala is a gastroenterology specialist in Raleigh, NC, with 14 years of NPI registration. Based on federal Medicare data, Dr. Vanpala performed 340 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Vanpala received a total of $39,832 from 92 pharmaceutical and/or device companies across 2106 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vanpala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years of NPI registration ▲ 340 Medicare services $39,832 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
340
Medicare services
Bottom 31% in NC for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
251 $76 $106
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
89 $113 $113
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$39,832
Total received (2018-2024)
Avg $5,690/year across 7 years
Top 8% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
2,106
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,051
2023
$6,178
2022
$8,278
2021
$6,661
2020
$3,329
2019
$4,794
2018
$4,541

Payments by company (2024)

ABBVIE INC.
$716
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$539
Amgen Inc.
$418
AstraZeneca Pharmaceuticals LP
$413
Novo Nordisk Inc
$386
Phathom Pharmaceuticals, Inc.
$338
Axsome Therapeutics, Inc.
$324
PFIZER INC.
$301
Otsuka America Pharmaceutical, Inc.
$285
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$207
IDORSIA PHARMACEUTICALS US INC
$204
Lilly USA, LLC
$177
Sonex Health, Inc.
$151
Lundbeck LLC
$148
Ardelyx, Inc.
$117
Corcept Therapeutics
$116
Janssen Pharmaceuticals, Inc
$105
AIMMUNE THERAPEUTICS, INC.
$101
Bayer Healthcare Pharmaceuticals Inc.
$97
Verity Pharmaceuticals Inc.
$92
IBSA Pharma Inc.
$90
Exact Sciences Corporation
$83
QOL Medical, LLC
$77
Takeda Pharmaceuticals U.S.A., Inc.
$76
Teva Pharmaceuticals USA, Inc.
$74
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Paratek Pharmaceuticals, Inc.
$54
Tolmar, Inc.
$52
Esperion Therapeutics, Inc.
$52
Antares Pharma, Inc.
$50
Novartis Pharmaceuticals Corporation
$44
Regeneron Healthcare Solutions, Inc.
$24
Merck Sharp & Dohme LLC
$18
Astellas Pharma US Inc
$18
Currax Pharmaceuticals LLC
$17
Radius Health, Inc.
$15
Acella Pharmaceuticals, LLC
$13
Top 3 companies account for 27.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$6,709
Novo Nordisk Inc
$3,934
AbbVie Inc.
$2,461
AstraZeneca Pharmaceuticals LP
$2,144
Lilly USA, LLC
$1,751
ABBVIE INC.
$1,504
Allergan Inc.
$1,424
Amarin Pharma Inc.
$1,217
Supernus Pharmaceuticals, Inc.
$905
Otsuka America Pharmaceutical, Inc.
$805
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$715
Takeda Pharmaceuticals U.S.A., Inc.
$669
ITI, Inc.
$666
PFIZER INC.
$592
Boehringer Ingelheim Pharmaceuticals, Inc.
$589
Eisai Inc.
$582
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$539
AbbVie, Inc.
$537
Allergan, Inc.
$534
Janssen Pharmaceuticals, Inc
$517
Teva Pharmaceuticals USA, Inc.
$514
IDORSIA PHARMACEUTICALS US INC
$477
Axsome Therapeutics, Inc.
$451
Antares Pharma, Inc.
$445
IBSA Pharma Inc.
$427
Clarus Therapeutics Inc.
$416
Currax Pharmaceuticals LLC
$365
Corcept Therapeutics
$357
Lundbeck LLC
$352
Esperion Therapeutics, Inc.
$351
Phathom Pharmaceuticals, Inc.
$338
Nestle HealthCare Nutrition Inc.
$318
GlaxoSmithKline, LLC.
$296
Tolmar, Inc.
$284
Merck Sharp & Dohme Corporation
$269
TherapeuticsMD, Inc.
$264
Paratek Pharmaceuticals, Inc.
$245
Bayer Healthcare Pharmaceuticals Inc.
$202
JAZZ PHARMACEUTICALS INC.
$199
Biohaven Pharmaceutical Holding Company Ltd.
$198
SANOFI-AVENTIS U.S. LLC
$196
Regeneron Healthcare Solutions, Inc.
$195
Astellas Pharma US Inc
$194
Exact Sciences Corporation
$190
Abbott Laboratories
$177
Gilead Sciences, Inc.
$177
Synergy Pharmaceuticals Inc
$169
Sonex Health, Inc.
$168
IMPEL PHARMACEUTICALS INC.
$147
QOL Medical, LLC
$146
Sunovion Pharmaceuticals Inc.
$133
Merck Sharp & Dohme LLC
$129
Ardelyx, Inc.
$117
Phadia US Inc.
$115
AIMMUNE THERAPEUTICS, INC.
$101
Bayer HealthCare Pharmaceuticals Inc.
$101
ARBOR PHARMACEUTICALS, INC.
$99
Endo Pharmaceuticals Inc.
$98
Novartis Pharmaceuticals Corporation
$97
Shield Therapeutics Inc
$96
Biohaven Pharmaceuticals, Inc.
$95
Verity Pharmaceuticals Inc.
$92
NESTLE HEALTHCARE NUTRITION INC.
$92
Boston Scientific Corporation
$86
Medtronic, Inc.
$83
Avanir Pharmaceuticals, Inc.
$78
VIVUS, Inc.
$77
E.R. Squibb & Sons, L.L.C.
$75
Nabriva Therapeutics, plc
$64
Aytu BioScience, Inc
$60
Acerus Pharmaceuticals Corporation
$56
EISAI INC.
$47
Arbor Pharmaceuticals, Inc.
$47
VIVUS LLC
$47
IRONWOOD PHARMACEUTICALS, INC
$46
FIDIA PHARMA USA INC.
$41
Nalpropion Pharmaceuticals, Inc.
$36
Azurity Pharmaceuticals, Inc.
$31
Nalpropion Pharmaceuticals LLC
$29
Avion Pharmaceuticals
$28
Genentech USA, Inc.
$26
Acella Pharmaceuticals, LLC
$26
Xeris Pharmaceuticals, Inc.
$25
Astellas Pharma Global Development
$20
Orexigen Therapeutics, Inc.
$18
Horizon Therapeutics plc
$18
Duchesnay USA Incorporated
$17
AMAG Pharmaceuticals, Inc.
$15
Radius Health, Inc.
$15
Adlon Therapeutics L.P.
$13
Bausch Health US, LLC
$11
Sumitomo Pharma America, Inc.
$11
Top 3 companies account for 32.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ACCRUFER · ADHANSIA XR · AIRSUPRA · AJOVY · ANNOVERA · ANORO · ANORO ELLIPTA · APLENZIN · AUSTEDO · AVEED · Adthyza · Aimovig · Amitiza · Auvelity · BASAGLAR · BELSOMRA · BIJUVA · BREZTRI · BYDUREON · BYSTOLIC · Balcoltra · Belviq · CAPLYTA · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · CREON · Cologuard Collection Kit · Creon · Dayvigo · Descovy · Dexilant · Divigel · EDEX · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edarbyclor · Evekeo · FARXIGA · FASENRA · FORTEO · FREESTYLE LIBRE 3 · GARDASIL · GATTEX · GEMTESA · GLASSIA · GVOKE PFS · Horizant · Hymovis · IBSRELA · IMVEXXY · INTELLIS · INTELLIS ADAPTIVESTIM · INTRAROSA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · Levemir · Linzess · MOUNJARO · MOVANTIK · NEXLETOL · NEXLIZET · NOCDURNA · NP Thyroid 60 · NURTEC ODT · NUZYRA · Natesto · Nuedexta · ONZETRA XSAIL · OTREXUP · OXTELLAR XR · Osphena · Otezla · Otovel · Otrexup · Ozempic · PAXLOVID · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · Proclaim IPG · Prolia · QELBREE · QSYMIA · QULIPTA · QUVIVIQ · Qsymia · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SPRAVATO · STEGLATRO · SUCRAID · SUNOSI · SX-ONE MICROKNIFE · SYMBICORT · Saxenda · Sivextro · Sucraid · Sunosi · TESTOPEL · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · Tirosint · Tlando · Tresiba · Trintellix · Trudhesa · Trulance · Truvada · Tymlos · UBRELVY · UTIBRON NEOHALER · Uloric · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIAFLEX · XIFAXAN · XYOSTED · Xenleta · Xofluza · Xultophy 100/3.6 · ZAVZPRET · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a gastroenterology specialist in Raleigh?
Compare gastroenterologists in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists in nearby ZIP areas
109
County median income
$101,763
Nearest hospital to ZIP centroid (approximate)
REX HOSPITAL
5.6 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vanpala is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vanpala experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vanpala performed 251 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vanpala receive payments from pharmaceutical companies?
Yes. Dr. Vanpala received a total of $39,832 from 92 companies across 2,106 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vanpala's costs compare to other gastroenterologists in Raleigh?
Dr. Vanpala's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vanpala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →